PolyVD is a high-risk subset of ACS patients and should be identified before patients are admitted to the hospital. It is an independent predictor of short-term and long-term mortality and poorer hospital outcomes. Prevention efforts should be focused on polyVD, which should include looking for other affected vascular beds. This will be an important step in risk stratification.
CAD in young adults
There is limited knowledge of the incidence of CAD in young adults, particularly in the Southeast Asian region. This study will assess the incidence of young CAD, its risk factor profile, and clinical outcomes. These data may provide a framework for primary and secondary prevention. The study will also examine the role of physical activity and diet in reducing the incidence of CAD.
The study found a higher risk of MACEs among patients with polyVD. The risk of MACEs increased with the number of vascular beds involved in the disease. The number of plaques also correlated with poor outcomes.
CAD in women
Cardiovascular diseases are the leading cause of death in developed countries, accounting for over half of all deaths. The leading causes of mortality are myocardial infarction and ischaemic stroke. These diseases are becoming more common with the aging population. Polyvascular atherosclerosis can have a significant impact on cardiovascular morbidity and mortality.
While the risk of myocarditis was lower in women than in men, the rate of death was higher. For example, men had an incidence of one death for every five cases, while women had a 0.7 fatality rate per case. Overall, polyvascular coronary artery disease (CAD) is more common among women than in men.
CAD in women with prior polyvascular coronary artery disease
Women with prior polyvascular coronary artery disease (PVD) have an increased risk of developing CAD. This is due to the fact that their PVD is often poorly managed compared with single-bed artery disease. PVD is also more likely to cause carotid artery disease.
The study was funded by the Bill and Melinda Gates Foundation and the National Institutes of Health. Drs. Bhatt and Pollak are Mayo Clinic physicians and directors of cardiac subspecialties. Dr. Brauer is a professor of medicine at the University of Colorado and vascular researcher.
CAD in young adults with prior polyvascular coronary artery disease
Patients with prior polyvascular coronary artery disease are at a higher risk of developing CAD. These patients often have multiple underlying conditions, such as peripheral vascular disease and cerebrovascular disease. Additionally, these patients have higher risk of occurrence of in-hospital adverse events. There is little research available on the long-term outcomes of these patients.
This study included patients aged 65 or younger with a history of coronary artery disease (CAD). The patients were linked to longitudinal data from the Centers for Medicare and Medicaid Services (CMS). The patients were presumed to have prior coronary artery disease, although not all of them had this type of disease. Among these patients, 10.7% had prior CVD or PAD, and 3.1% had prior PAD and CVD. Another 14.3% of the patients did not have polyvascular disease.
In the United States, cardiovascular disease is the leading cause of death, with a large proportion of deaths being associated with ischemic disease. Thus, much research has focused on identifying those at risk of developing CAD. One subset of these patients is those with polyvascular disease (PVD), which is characterized by a history of ischemic disease and includes coronary artery disease, peripheral arterial disease, and cerebrovascular disease. While prior studies have shown a high prevalence of PVD, no current guidelines encourage routine screening for the disease, despite the fact that this subset has a much higher risk of developing CAD than other patients with the same risk factor.
Rates of ischemic events in patients with polyvascular coronary artery disease
Patients with coronary artery disease (CAD) who have more than one artery have an increased risk of developing ischemic events. This condition can lead to heart failure, or it may be the cause of a broader range of cardiovascular events, such as stroke. Polyvascular CAD has been shown to lead to a poor prognosis. Moreover, it can lead to a higher risk of death, so it is important to find ways to prevent it.
The authors of this study found that patients with HFpEF who also had PVD had a higher rate of cardiovascular events than those with single-bed artery disease. These findings suggest that detecting PVD at an early stage is important for risk stratification and treatment of HFpEF. They were also able to identify factors that could influence the occurrence of PVD in patients.